Filter
2021
Filtered Results: 2021
Text search:
drug
regimens
Featured
Recommendations
207
New Publications
525
Language
Document type
No document type
1280
Guidelines
293
Studies & Reports
259
Manuals
67
Strategic & Response Plan
39
Fact sheets
35
Training Material
26
Situation Updates
7
Infographics
7
Resource Platforms
4
Brochures
2
Online Courses
2
Countries / Regions
India
120
South Africa
65
Global
54
Kenya
52
Ethiopia
48
Tanzania
47
Western and Central Europe
42
Uganda
38
Nigeria
36
Zambia
36
Nepal
31
Eastern Europe
31
Rwanda
28
Africa
25
Latin America and the Carribbean
25
Malawi
24
Namibia
23
Ghana
22
Ukraine
21
Liberia
20
Philippines
18
Asia
18
Bangladesh
18
Myanmar / Burma
18
Zimbabwe
16
Cambodia
14
Sierra Leone
13
Mozambique
12
South–East Asia Region
12
Russia
12
Lesotho
11
Indonesia
11
Botswana
10
Eswatini/ Swaziland
8
Colombia
7
Thailand
7
Cameroon
7
Senegal
7
Congo, Democratic Republic of
6
Brazil
6
Albania
5
Haiti
5
Georgia
5
Tajikistan
4
Syria
4
USA
4
Venezuela
4
West and Central Africa
4
East and Southern Africa
4
Argentina
4
Pakistan
4
Benin
3
China
3
Estonia
3
Germany
3
Western Pacific Region
3
Jamaica
3
Vietnam
3
Bhutan
3
South Sudan
3
Timor Leste/ East Timor
2
Burkina Faso
2
Afghanistan
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
Sri Lanka
2
Sudan
2
Romania
2
Iraq
2
Somalia
2
North Macedonia
1
North Korea
1
El Salvador
1
Gambia
1
Chile
1
Iran
1
Fiji
1
Laos
1
Peru
1
Morocco
1
Guinea
1
Jordan
1
Saudi Arabia
1
Middle East and North Africa
1
Denmark
1
Tunisia
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Oman
1
Lebanon
1
Papua New Guinea
1
Greece
1
Central African Republic
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
728
Clinical Guidelines
274
Public Health
82
Women & Child Health
70
Capacity Building
40
Key Resources
27
Pharmacy & Technologies
18
Toolboxes
TB
381
HIV
354
NTDs
93
AMR
78
Pharmacy
60
Mental Health
48
COVID-19
45
NCDs
44
Malaria
33
Ebola & Marburg
29
Refugee
23
Caregiver
23
Rapid Response
16
Conflict
16
Polio
11
Disability
9
Health Financing Toolbox
7
Specific Hazards
4
Natural Hazards
4
Planetary Health
4
Global Health Education
4
Cholera
3
Social Ethics
3
Zika
1
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
Pneumonia kills more children than any other illness – more than AIDS, malaria and measles combined. Over 2 million children die from pneumonia each year, accounting for almost 1 in 5 under five deaths worldwide. Yet, little attention is paid to this disease. This joint UNICEF/WHO report examines ...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
J Hepatol (2017), http://dx.doi.org/10.1016/j.jhep.2017.03.021
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ...
Prepared as an outcome of ICMR Subcommittee on Buccal Mucosa Cancer | This consensus document on management of Buccal Mucosa cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. ...
Accessed Febr. 6, 2020
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with HIV (PLHIV). Our objective was to calculate the incidence, to describe the main cau...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
International Journal of Infectious Diseases 70 (2018) 121–130
https://doi.org/10.1016/j.ijid.2018.03.007
1201-9712/© 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://cr...
